Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAP3K7 | O43318 | 1/20 | 0.40 |
| ▸ | TAB1 | Q15750 | 1/20 | 0.40 |
| ▸ | MAPK14 | Q16539 | 12/20 | 0.40 |
| ▸ | MAPK12 | P53778 | 11/20 | 0.40 |
| ▸ | MAPK13 | O15264 | 10/20 | 0.40 |
| ▸ | MAPK11 | Q15759 | 10/20 | 0.40 |
| ▸ | DDR2 | Q16832 | 1/20 | 0.39 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.39 |
| ▸ | SRC | P12931 | 1/20 | 0.39 |
| ▸ | SYK | P43405 | 1/20 | 0.39 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.38 |
| ▸ | PRKAB2 | O43741 | 1/20 | 0.38 |
| ▸ | NUAK1 | O60285 | 1/20 | 0.38 |
| ▸ | CCNT1 | O60563 | 1/20 | 0.38 |
| ▸ | ABL1 | P00519 | 1/20 | 0.38 |
| ▸ | FYN | P06241 | 1/20 | 0.38 |
| ▸ | CDK1 | P06493 | 1/20 | 0.38 |
| ▸ | CSF1R | P07333 | 1/20 | 0.38 |
| ▸ | RET | P07949 | 1/20 | 0.38 |
| ▸ | PDGFRB | P09619 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5062301 | 0.93 | BRAF (0.45) | MAP3K7TAB1MAPK14MAPK12MAPK13 | |
| SCHEMBL5052355 | 0.90 | MAPK14 (0.51) | MAP3K7TAB1MAPK14MAPK12MAPK13 | |
| SCHEMBL5056737 | 0.89 | BRAF (0.45) | MAPK14MAPK12MAPK13MAPK11DDR2 | |
| SCHEMBL5054835 | 0.89 | MAPK14 (0.42) | MAPK14MAPK12MAPK13MAPK11DDR2 | |
| SCHEMBL5054594 | 0.89 | MAPK14 (0.49) | MAP3K7TAB1MAPK14MAPK12MAPK13 | |
| SCHEMBL5054916 | 0.87 | MAPK14 (0.41) | MAPK14MAPK12MAPK13MAPK11DDR2 | |
| SCHEMBL5055157 | 0.87 | MAPK14 (0.46) | MAPK14MAPK12MAPK13MAPK11DDR2 | |
| SCHEMBL5056600 | 0.86 | MAPK14 (0.40) | MAPK14MAPK12MAPK13MAPK11DDR2 | |
| SCHEMBL5052094 | 0.82 | MAPK14 (0.39) | MAP3K7TAB1MAPK14MAPK12MAPK13 | |
| SCHEMBL5062104 | 0.81 | BRAF (0.48) | MAP3K7TAB1MAPK14MAPK12MAPK13 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080113967-A1 | ENZYME MODULATORS AND TREATMENTS | DECIPHERA PHARMACEUTICALS, LLC (US) | 2008-05-15 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080113967-A1 | ENZYME MODULATORS AND TREATMENTS | ABL2, BRAF, MAP3K1 | MAP3K7 22/4885TAB1 240/4885MAPK14 100/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.